)
From Molecule to Market: Harnessing AI to Predict Drug Success and Drive Business Growth
Dec 10, 2025
Health & Pharma Stage
Health & Pharma
- Generative AI is transforming biotech investments by predicting trial outcomes, measuring market share, and identifying potential partners for in-licensing or out-licensing
- This session explores how Gen AI and predictive models are evaluating molecule potential, estimating FDA approval probabilities, collecting competitive intelligence, and identifying deal partners
- Hear how data is being harnessed by Gen AI to accelerate decision-making for asset portfolio managers and drive smarter strategies in health and pharma innovation
Session Type
Presentation
Content Focus
Strategy
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
){kind=logo}
)
.svg){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
.jpg/fit-in/500x500/filters:no_upscale()){kind=logo}
)
.jpg/fit-in/500x500/filters:no_upscale())
){kind=logo}
){kind=logo}
)
)
)
)
)
)
){kind=logo}
)